⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NUVAMA - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 4

Last Updated Time : 02 Feb 26, 01:17 pm

Fundamental Rating: 4.0

Stock Code NUVAMA Market Cap 22,672 Cr. Current Price 1,246 ₹ High / Low 1,702 ₹
Stock P/E 39.4 Book Value 109 ₹ Dividend Yield 2.32 % ROCE 30.6 %
ROE 32.6 % Face Value 2.00 ₹ DMA 50 1,411 ₹ DMA 200 1,375 ₹
Chg in FII Hold 0.09 % Chg in DII Hold 0.78 % PAT Qtr 280 Cr. PAT Prev Qtr 46.4 Cr.
RSI 32.9 MACD -41.2 Volume 19,76,353 Avg Vol 1Wk 10,49,833
Low price 914 ₹ High price 1,702 ₹ PEG Ratio 0.27 Debt to equity 0.19
52w Index 42.2 % Qtr Profit Var 35.5 % EPS 31.8 ₹ Industry PE 19.1

📊 Core Financials

  • Revenue & Profitability: Quarterly PAT rose sharply from 46.4 Cr. to 280 Cr. (+35.5%), showing strong earnings momentum. EPS at 31.8 ₹ reflects solid profitability.
  • Margins: ROCE at 30.6% and ROE at 32.6% highlight excellent efficiency and shareholder returns.
  • Debt: Debt-to-equity ratio of 0.19 indicates low leverage, strengthening financial stability.
  • Cash Flow: Dividend yield of 2.32% provides attractive shareholder returns, supported by healthy cash flows.

💹 Valuation Indicators

  • P/E Ratio: 39.4 vs Industry PE of 19.1 → Overvalued compared to peers.
  • P/B Ratio: Current Price (1,246 ₹) / Book Value (109 ₹) ≈ 11.4 → Premium valuation.
  • PEG Ratio: 0.27 → Attractive, suggesting growth potential relative to price.
  • Intrinsic Value: Current price trades above fair value, limiting near-term upside but supported by strong earnings growth.

🏭 Business Model & Competitive Advantage

  • Nuvama operates in financial services, including wealth management, capital markets, and advisory.
  • Strong brand presence and diversified offerings provide competitive advantage.
  • Low debt and high return ratios strengthen long-term sustainability.

📈 Entry Zone & Long-Term Guidance

  • Entry Zone: Attractive accumulation range between 1,050 ₹ – 1,100 ₹, closer to DMA 200 support levels.
  • Long-Term Holding: Suitable for investors seeking exposure to financial services growth. Staggered buying recommended due to premium valuations and volatility.

✅ Positive

  • Quarterly PAT growth (+35.5%) shows strong earnings momentum.
  • High ROCE (30.6%) and ROE (32.6%) highlight efficiency.
  • Debt-to-equity ratio of 0.19 ensures financial resilience.
  • Dividend yield of 2.32% provides attractive income.
  • FII holding increased by 0.09% and DII holding by 0.78%, showing institutional confidence.

⚠️ Limitation

  • High P/E (39.4) and P/B (11.4) ratios indicate stretched valuations.
  • PEG ratio attractive, but valuation multiples remain elevated.
  • MACD at -41.2 suggests weak near-term momentum.

📉 Company Negative News

  • Valuation multiples remain significantly higher than industry averages.
  • Near-term technical indicators show weak momentum.

📈 Company Positive News

  • Quarterly PAT rose from 46.4 Cr. to 280 Cr.
  • FII inflows (+0.09%) and DII inflows (+0.78%) highlight institutional support.
  • Strong dividend yield supports shareholder value.

🌐 Industry

  • Financial services sector benefits from rising wealth creation, capital market activity, and advisory demand.
  • Industry PE at 19.1 suggests Nuvama trades at a premium, reflecting growth expectations and brand strength.

🔎 Conclusion

Nuvama demonstrates strong fundamentals with high return ratios, low debt, and robust earnings growth. However, valuations are stretched with high P/E and P/B multiples, and technical indicators show weak momentum. Investors may consider entering around 1,050–1,100 ₹ for long-term holding, with staggered buying to manage valuation risks. The company remains strategically well-positioned to benefit from India’s growing financial services industry.

I can also outline technical support and resistance zones using RSI, MACD, and DMA data to complement this fundamental analysis if you’d like.

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist